RUNX1 and acute lymphoblastic leukemia: The present study revealed that the group of ALL patients had significantly higher RUNX1 gene expression level compared with the controls (p = 0.028); furthermore, the high-risk group of ALL patients also presented significantly higher RUNX1 levels (p = 0.012).